Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-2-20
pubmed:abstractText
Our groups have reported that tumor necrosis factor-alpha (TNF-alpha) causes myelin damage and apoptosis of oligodendrocytes and their precursors in vitro and in vivo. We also have reported that insulin-like growth factor-I (IGF-I) can protect cultured oligodendrocytes and their precursors from TNF-alpha-induced damage. In this study, we investigated whether IGF-I can protect oligodendrocytes and myelination from TNF-alpha-induced damage in vivo by cross-breeding TNF-alpha transgenic (Tg) mice with IGF-I Tg mice that overexpress IGF-I exclusively in brain. At 8 weeks of age, compared with those of wild-type (WT) mice, the brain weights of TNF-alpha Tg mice were decreased by approximately 20%, and those of IGF-I Tg mice were increased by approximately 20%. The brain weights of mice that carry both TNF-alpha and IGF-I transgenes (TNF-alpha/IGF-I Tg mice) did not differ from those of WT mice. As judged by histochemical staining and immunostaining, myelin content in the cerebellum of TNF-alpha/IGF-I Tg mice was similar to that in WT mice and much more than that in TNF-alpha Tg mice. Consistently, Western immunoblot analysis showed that myelin basic protein (MBP) abundance in the cerebellum of TNF-alpha/IGF-I Tg mice was double that in TNF-alpha Tg mice. In comparison with WT mice, the number of oligodendrocytes was decreased by approximately 36% in TNF-alpha Tg mice, whereas it was increased in IGF-I Tg mice by approximately 40%. Oligodendrocyte number in TNF-alpha/IGF-I Tg mice was almost twice that in TNF-alpha Tg mice. Furthermore, IGF-I overexpression significantly reduced TNF-alpha-induced increases in apoptotic cell number, active caspase-3 abundance, and degradaion of MBP. Our results indicate that IGF-I is capable of protecting myelin and oligodendrocytes from TNF-alpha-induced damage in vivo.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-10385398, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-10417663, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-10908609, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-11104508, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-11222638, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-11600888, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-12122065, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-12584730, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-1315903, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-1371885, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-15484699, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-15765524, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-1647481, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-7472483, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-7472488, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-7479982, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-7493400, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-7541143, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-8386530, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-8402902, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-8430320, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-8786848, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-8873975, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-8977220, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-9094982, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-9421399, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-9736024, http://linkedlifedata.com/resource/pubmed/commentcorrection/17279553-9736029
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0360-4012
pubmed:author
pubmed:issnType
Print
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
712-22
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:17279553-Animals, pubmed-meshheading:17279553-Antigens, pubmed-meshheading:17279553-Caspase 3, pubmed-meshheading:17279553-Cell Count, pubmed-meshheading:17279553-Cerebellum, pubmed-meshheading:17279553-Demyelinating Diseases, pubmed-meshheading:17279553-Female, pubmed-meshheading:17279553-Gene Expression Regulation, pubmed-meshheading:17279553-Glutathione S-Transferase pi, pubmed-meshheading:17279553-Immunohistochemistry, pubmed-meshheading:17279553-In Situ Nick-End Labeling, pubmed-meshheading:17279553-Insulin-Like Growth Factor I, pubmed-meshheading:17279553-Male, pubmed-meshheading:17279553-Mice, pubmed-meshheading:17279553-Mice, Transgenic, pubmed-meshheading:17279553-Myelin Basic Proteins, pubmed-meshheading:17279553-Organ Size, pubmed-meshheading:17279553-Proteoglycans, pubmed-meshheading:17279553-RNA, Messenger, pubmed-meshheading:17279553-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:17279553-Tumor Necrosis Factor-alpha
pubmed:year
2007
pubmed:articleTitle
Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice.
pubmed:affiliation
Division of Endocrinology, Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7039, USA. ping_ye@med.unc.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural